News
HSS Annual General Meeting 2025
The Haemophilia Society of Singapore (HSS) held our Annual General Meeting yesterday — our first ever blended AGM, with a strong turnout of about 60 participants (40 in-person and 20 online).
We were honoured to hear from Dr Yap, Senior Haematologist at NUH, who shared the remarkable progress in haemophilia care. Treatment has expanded beyond standard factor therapy to include extended half-life factors, non-factor options, and even full gene therapy. It was inspiring to glimpse what the future of treatment may look like.
Thanks to the generous support of our donors and the hard work of the HSS committee, we closed the year with a strong surplus, further strengthening our reserves. We also highlighted a major policy change: prophylactic treatment is now covered under MediShield and Medisave, significantly easing the financial burden of proper care for our members.
HSS also announced our evolution — from being primarily a provider of treatment subsidies to now also focusing on advocacy and community-building. And as 2025 marks our 40th anniversary, we look forward to celebrating with a commemorative lunch this November (details will be shared soon on our Facebook page).
The AGM concluded with the election of the 2025/26 committee:
| President: | Gerald Foo |
| Vice President: | Melvin Tan |
| Honorary Secretary: | Tang Ying Wei |
| Honorary Treasurer: | Ng Leong Chin |
| Committee Members: | Tan Kai Ern, Dayvid Foo, Tang Wei Ze Alex |
We warmly thank Chun Woei Chee for his dedicated leadership as President, and are pleased to share that the Board will continue to be supported by our Honorary Advisors.
Here’s to the next chapter of HSS — stronger together, for the haemophilia community in Singapore.
